Geode Capital Management, LLC Vaxxinity, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Vaxxinity, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 878,543 shares of VAXX stock, worth $140,566. This represents 0.0% of its overall portfolio holdings.
Number of Shares
878,543
Previous 842,014
4.34%
Holding current value
$140,566
Previous $715,000
11.61%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VAXX
# of Institutions
58Shares Held
12.2MCall Options Held
0Put Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA3MShares$480,0000.0% of portfolio
-
Black Rock Inc. New York, NY2.62MShares$419,6880.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$385,8680.0% of portfolio
-
State Street Corp Boston, MA799KShares$127,8830.0% of portfolio
-
Northern Trust Corp Chicago, IL333KShares$53,3200.0% of portfolio
About Vaxxinity, Inc.
- Ticker VAXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 112,150,000
- Market Cap $17.9M
- Description
- Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...